Atlas Trials

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

Clinical trial NCT01705691 · COMPLETED

Trial details

NCT number
NCT01705691
Sponsor
NSABP Foundation Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerHER2-negative Breast Cancer
Start date
2012-09-01
Primary completion
2014-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.